Vir Biotechnology, Inc. · NASDAQ:VIR
Robert Nelsen reported a 8.50% stake in Vir Biotechnology, Inc. (Schedule 13D/A)
Event Feb 27, 2026 · Filed Mar 3, 2026
Robert Nelsen reported a 8.50% stake in Vir Biotechnology, Inc., 13,534,704 shares, with active intent on Feb 27, 2026. Filed Mar 3, 2026 (Schedule 13D/A).
- Stake
- 8.50%
- Shares
- 13,534,704
- Intent
- Active
- What changed
- Stake changed
- Filed together
- 8 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| ARCH Venture Fund IX, L.P. | 8.10% | 12,916,663 |
| ARCH Venture Fund IX Overage, L.P. | 8.10% | 12,916,663 |
| ARCH Venture Partners IX, L.P. | 8.10% | 12,916,663 |
| ARCH Venture Partners IX Overage, L.P. | 8.10% | 12,916,663 |
| ARCH Venture Partners IX, LLC | 8.10% | 12,916,663 |
| Robert Nelsen | 8.50% | 13,534,704 |
| Keith Crandell | 8.30% | 13,189,627 |
| Clinton Bybee | 8.10% | 13,008,393 |